These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36536215)

  • 1. Why children have to wait years for new drugs.
    Singh Chawla D
    Nature; 2022 Dec; 612(7941):S54-S55. PubMed ID: 36536215
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results.
    Hwang TJ; Carpenter D; Lauffenburger JC; Wang B; Franklin JM; Kesselheim AS
    JAMA Intern Med; 2016 Dec; 176(12):1826-1833. PubMed ID: 27723879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The review process and some consideration of the assessment in committee on clinical practice of investigational new drugs in Nippon Medical School].
    Takahashi F; Aso R; Ohashi K; Gotoh Y
    Nihon Ika Daigaku Zasshi; 1991 Aug; 58(4):89-93. PubMed ID: 1918277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patients: can you wait just a bit longer?].
    Junod V
    Rev Med Suisse; 2006 Nov; 2(89):2757-9. PubMed ID: 17300097
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks in new drug development: approval success rates for investigational drugs.
    Dimasi JA
    Clin Pharmacol Ther; 2001 May; 69(5):297-307. PubMed ID: 11371997
    [No Abstract]   [Full Text] [Related]  

  • 6. Why So Few New Cardiovascular Drugs Translate to the Clinics.
    Vatner SF
    Circ Res; 2016 Sep; 119(6):714-7. PubMed ID: 27587410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why Does the FDA Place Clinical Holds on Investigational New Drug Clinical Trials?
    Miller DJ
    ONS Connect; 2016 Dec; 31(12):24. PubMed ID: 30550676
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of investigational drugs as initial therapy for childhood solid tumors.
    Meyer WH; Houghton PJ; Horowitz ME; Etcubanas E; Pratt CB; Hayes FA; Thompson EI; Green AA; Houghton JA; Sandlund JT
    Haematol Blood Transfus; 1989; 32():141-8. PubMed ID: 2625241
    [No Abstract]   [Full Text] [Related]  

  • 9. Why research in medicine needs a step back? Editorial.
    Fais S
    Ann Ist Super Sanita; 2020; 56(1):3-5. PubMed ID: 32242529
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug screening in Drosophila; why, when, and when not?
    Su TT
    Wiley Interdiscip Rev Dev Biol; 2019 Nov; 8(6):e346. PubMed ID: 31056843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

  • 12. Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study.
    Viner RM; Hsia Y; Neubert A; Wong IC
    Br J Clin Pharmacol; 2009 Dec; 68(6):844-51. PubMed ID: 20002078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why Are Innovative Drugs Failing in Phase III?
    Marder SR; Laughren T; Romano SJ
    Am J Psychiatry; 2017 Sep; 174(9):829-831. PubMed ID: 28859511
    [No Abstract]   [Full Text] [Related]  

  • 14. ['The wait is for new concepts' Interview by Hans van Maanen].
    Vandenbroucke-Grauls C
    Ned Tijdschr Geneeskd; 2007 Jan; 151(1):86-8. PubMed ID: 17583049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access].
    Goldim JR
    Rev Panam Salud Publica; 2008 Mar; 23(3):198-206. PubMed ID: 18397586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs being investigated for children with COVID-19.
    Deniz M; Tapısız A; Tezer H
    Acta Paediatr; 2020 Sep; 109(9):1905-1906. PubMed ID: 32506621
    [No Abstract]   [Full Text] [Related]  

  • 17. Open letter to scientific journals, the pharmaceutical industry and drugs approval authorities. ESPE Drugs and Therapeutics Committee. European Society of Paediatric Endocrinology.
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):501. PubMed ID: 9404450
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiologics and drugs available from the Centers for Disease Control.
    Becher JA; Parvin RM; Van Assendelft OW
    J Pharm Technol; 1989; 5(4):181-6. PubMed ID: 10314382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The next generation of gout therapeutics: ready for prime time?
    Abeles AM; Pillinger MH
    Curr Rheumatol Rep; 2011 Apr; 13(2):100-2. PubMed ID: 21140246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.